Peroxiredoxin-1 (Fragment)
AltitudeomicsDB
Protein Official symbol |
PRDX1 |
Aliases |
PRDX1 PAGA PAGB TDPX2 |
Chromosomal Location |
1 |
Length |
199 |
Uniprot ID |
Q06830 |
EC number |
1.11.1.24 |
Protein family Information(Pfam) |
PF10417;PF00578; |
PDB id |
2RII;3HY2;4XCS; |
InterPro ID |
IPR000866;IPR024706;IPR019479;IPR036249;IPR013766; |
dbSNP |
rs34034070 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
CDK5 |
CDK5R1 |
0.992 |
TXN |
PRDX1 |
0.987 |
CDK5 |
TP53 |
0.978 |
PRDX1 |
SESN2 |
0.974 |
TP53 |
SESN2 |
0.974 |
TXN |
TP53 |
0.972 |
AR |
PRDX1 |
0.951 |
TP53 |
PRDX1 |
0.938 |
SESN3 |
PRDX1 |
0.935 |
SESN3 |
TP53 |
0.933 |
CDK5R1 |
TP53 |
0.915 |
CDK5 |
PRDX1 |
0.912 |
SESN3 |
SESN2 |
0.903 |
CDK5R1 |
PRDX1 |
0.9 |
Gene Ontology Semantic Similarity
Download Tab separated file
# |
1020 (CDK5) |
7295 (TXN) |
5052 (PRDX1) |
7157 (TP53) |
367 (AR) |
143686 (SESN3) |
8851 (CDK5R1) |
83667 (SESN2) |
1020 (CDK5)
|
1.00
|
0.42
|
0.44
|
0.47
|
0.47
|
0.45
|
0.70
|
0.43
|
7295 (TXN)
|
0.42
|
1.00
|
0.72
|
0.56
|
0.57
|
0.57
|
0.48
|
0.51
|
5052 (PRDX1)
|
0.44
|
0.72
|
1.00
|
0.55
|
0.55
|
0.68
|
0.52
|
0.67
|
7157 (TP53)
|
0.47
|
0.56
|
0.55
|
1.00
|
0.81
|
0.51
|
0.53
|
0.50
|
367 (AR)
|
0.47
|
0.57
|
0.55
|
0.81
|
1.00
|
0.50
|
0.48
|
0.49
|
143686 (SESN3)
|
0.45
|
0.57
|
0.68
|
0.51
|
0.50
|
1.00
|
0.50
|
0.93
|
8851 (CDK5R1)
|
0.70
|
0.48
|
0.52
|
0.53
|
0.48
|
0.50
|
1.00
|
0.48
|
83667 (SESN2)
|
0.43
|
0.51
|
0.67
|
0.50
|
0.49
|
0.93
|
0.48
|
1.00
|
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
PRDX1 |
Human |
Blood |
- |
3600 m |
Native |
upregulated |
- |
TMT-based proteomic analysis/LC-MS |
Central Asia |
Tibetans |
- |
High altitude native vs. low Lander |
30908922 |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
5052 |
GO:0042267 |
natural killer cell mediated cytotoxicity |
GOTERM_BP_DIRECT |
5052 |
GO:0098609 |
cell-cell adhesion |
GOTERM_BP_DIRECT |
5052 |
GO:0042345 |
regulation of NF-kappaB import into nucleus |
GOTERM_BP_DIRECT |
5052 |
GO:0016209 |
antioxidant activity |
GOTERM_MF_DIRECT |
5052 |
GO:0045454 |
cell redox homeostasis |
GOTERM_BP_DIRECT |
5052 |
GO:0005739 |
mitochondrion |
GOTERM_CC_DIRECT |
5052 |
GO:0005829 |
cytosol |
GOTERM_CC_DIRECT |
5052 |
GO:0042470 |
melanosome |
GOTERM_CC_DIRECT |
5052 |
GO:0032872 |
regulation of stress-activated MAPK cascade |
GOTERM_BP_DIRECT |
5052 |
GO:0051920 |
Hsp90 protein binding |
GOTERM_MF_DIRECT |
5052 |
GO:0031012 |
extracellular matrix |
GOTERM_CC_DIRECT |
5052 |
GO:0055114 |
oxidation-reduction process |
GOTERM_BP_DIRECT |
5052 |
GO:0004601 |
peroxidase activity |
GOTERM_MF_DIRECT |
5052 |
GO:0005515 |
protein binding |
GOTERM_MF_DIRECT |
5052 |
GO:0008379 |
acetylglucosaminyltransferase activity |
GOTERM_MF_DIRECT |
5052 |
GO:0005623 |
cell |
GOTERM_CC_DIRECT |
5052 |
GO:0005634 |
nucleus |
GOTERM_CC_DIRECT |
5052 |
GO:0019430 |
removal of superoxide radicals |
GOTERM_BP_DIRECT |
5052 |
GO:0005737 |
cytoplasm |
GOTERM_CC_DIRECT |
5052 |
GO:0034101 |
erythrocyte homeostasis |
GOTERM_BP_DIRECT |
5052 |
GO:0042802 |
identical protein binding |
GOTERM_MF_DIRECT |
5052 |
GO:0098641 |
cadherin binding involved in cell-cell adhesion |
GOTERM_MF_DIRECT |
5052 |
GO:0001501 |
skeletal system development |
GOTERM_BP_DIRECT |
5052 |
GO:0016491 |
oxidoreductase activity |
GOTERM_MF_DIRECT |
5052 |
GO:0005913 |
cell-cell adherens junction |
GOTERM_CC_DIRECT |
5052 |
GO:0043209 |
myelin sheath |
GOTERM_CC_DIRECT |
5052 |
GO:0070062 |
extracellular exosome |
GOTERM_CC_DIRECT |
5052 |
GO:0042744 |
hydrogen peroxide catabolic process |
GOTERM_BP_DIRECT |
5052 |
GO:0000302 |
response to reactive oxygen species |
GOTERM_BP_DIRECT |
5052 |
GO:0001895 |
retina homeostasis |
GOTERM_BP_DIRECT |
5052 |
GO:0008283 |
cell proliferation |
GOTERM_BP_DIRECT |
5052 |
GO:0005615 |
extracellular space |
GOTERM_CC_DIRECT |
5052 |
GO:0044822 |
poly |
GOTERM_MF_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
5052 |
hsa04146 |
Peroxisome |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
PRDX1 |
5052 |
Lung Neoplasms |
C0024121 |
Neoplastic Process |
0.32 |
0.577 |
0.69 |
group |
PRDX1 |
5052 |
Methylmalonic acidemia with homocystinuria |
C1848561 |
Disease or Syndrome |
0.4 |
0.577 |
0.69 |
disease |
PRDX1 |
5052 |
Hepatoma, Novikoff |
C0019208 |
Experimental Model of Disease; Neoplastic Process |
0.3 |
0.577 |
0.69 |
disease |
PRDX1 |
5052 |
Keloid |
C0022548 |
Acquired Abnormality |
0.3 |
0.577 |
0.69 |
phenotype |
PRDX1 |
5052 |
Malignant neoplasm of lung |
C0242379 |
Neoplastic Process |
0.36 |
0.577 |
0.69 |
disease |
PRDX1 |
5052 |
Pulmonary Fibrosis - from Asbestos Exposure |
C2930617 |
Disease or Syndrome |
0.3 |
0.577 |
0.69 |
disease |
PRDX1 |
5052 |
Hepatoma, Morris |
C0019207 |
Experimental Model of Disease; Neoplastic Process |
0.3 |
0.577 |
0.69 |
disease |
PRDX1 |
5052 |
Liver Neoplasms, Experimental |
C0023904 |
Experimental Model of Disease; Neoplastic Process |
0.3 |
0.577 |
0.69 |
group |
PRDX1 |
5052 |
Squamous cell carcinoma of esophagus |
C0279626 |
Neoplastic Process |
0.32 |
0.577 |
0.69 |
disease |
PRDX1 |
5052 |
Non-Small Cell Lung Carcinoma |
C0007131 |
Neoplastic Process |
0.31 |
0.577 |
0.69 |
disease |
PRDX1 |
5052 |
Schistosomiasis |
C0036323 |
Disease or Syndrome |
0.3 |
0.577 |
0.69 |
disease |
PRDX1 |
5052 |
Liver carcinoma |
C2239176 |
Neoplastic Process |
0.34 |
0.577 |
0.69 |
disease |
PRDX1 |
5052 |
Asbestosis |
C0003949 |
Disease or Syndrome |
0.3 |
0.577 |
0.69 |
disease |
PRDX1 |
5052 |
Experimental Hepatoma |
C0086404 |
Experimental Model of Disease; Neoplastic Process |
0.3 |
0.577 |
0.69 |
disease |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |
PRDX1 |
5052 |
ANTIOXIDANT |
None |
None |
None |
PRDX1 |
5052 |
HYDROGEN PEROXIDE |
HYDROGEN PEROXIDE |
CHEMBL71595 |
None |